Female sex and burden of depressive symptoms predict insufficient response to telemedical treatment in adult attention-deficit/hyperactivity disorder

• Verfasst von: Praus, Peter [VerfasserIn]
• Verfasst von: Proctor, Tanja [VerfasserIn]
• Verfasst von: Rohrmann, Tobias [VerfasserIn]
• Verfasst von: Benedyk, Anastasia [VerfasserIn]
• Verfasst von: Tost, Heike [VerfasserIn]
• Verfasst von: Hennig, Oliver [VerfasserIn]
• Verfasst von: Meyer-Lindenberg, Andreas [VerfasserIn]
• Verfasst von: Wahl, Anna-Sophia [VerfasserIn]
• Titel: Female sex and burden of depressive symptoms predict insufficient response to telemedical treatment in adult attention-deficit/hyperactivity disorder
• Titelzusatz: results from a naturalistic patient cohort during the COVID-19 pandemic
• Verf.angabe: Peter Praus, Tanja Proctor, Tobias Rohrmann, Anastasia Benedyk, Heike Tost, Oliver Hennig, Andreas Meyer-Lindenberg and Anna-Sophia Wahl
• E-Jahr: 2023
• Jahr: 05 October 2023
• Umfang: 19 S.
• Fussnoten: Gesehen am 26.01.2024
• Titel Quelle: Enthalten in: Frontiers in psychiatry
• Ort Quelle: Lausanne : Frontiers Research Foundation, 2007
• Jahr Quelle: 2023
• Band/Heft Quelle: 14(2023), Artikel-ID 1193898, Seite 1-19
• ISSN Quelle: 1664-0640
• DOI: doi:10.3389/fpsyt.2023.1193898
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1879353113

Abstract

Background: Attention-deficit/hyperactivity disorder (ADHD) is a chronic neuropsychiatric disorder, that typically manifests itself during childhood and persists in a majority of the affected individuals into adulthood, negatively affecting physical and mental health. Previous studies have shown detrimental effects of the COVID-19 pandemic on mental health in individuals with ADHD. Thus, telemedicine could be a useful tool for optimizing treatment-outcomes in adult ADHD by improving treatment adherence and persistence. However, data on telemedical treatment outcomes in adult patients with ADHD is scarce. Methods: We report here the sub-cohort analysis of a naturalistic cohort of adult patients (N = 254) recruited between April 2020-April 2021, comparing the effects of telemedical treatment on participants either clinically diagnosed with depression (N = 54) or ADHD (N = 67). Participants were asked to fill out the WHO-5 repetitively during >12 weeks of telemedical treatment. Furthermore scores of WHO-5, SCL-90R and BDI-II, psychopathology, psychosocial functioning, sociodemographic data, medical records and a feedback survey were analyzed for both groups and compared. Participants with ADHD were further stratified according to the development of well-being during the study period in order to identify factors associated with a satisfactory treatment outcome. Results: Participants with depression reported a significant improvement of well-being during the course of the study, while no such effect could be seen in participants with ADHD on a group level. Despite the good outcome, participants with depression were more severely affected at baseline, with significantly worse psychopathology and a more precarious labor and financial situation. A detailed analysis of ADHD participants without clinical improvement revealed significantly higher BDI-II scores than for ADHD participants with a satisfactory outcome (p = 0.03, Mann-Whitney-U-Test), suggesting successful treatment was hampered by the combination of ADHD and depressive symptoms. Furthermore, female sex among ADHD patients was correlated with an unfavorable treatment outcome during the course of the study (p = 0.001, Spearman correlation) as well as living with children (p = 0.02, Spearman correlation). Conclusion: Besides screening for depressive symptoms before telemedical treatment, future research should address the specific needs of female ADHD patients as these patients may be at a particularly high risk of being overburdened with family work.